Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?

Lung Cancer

Volumn 68, Issue 1, 2010, Pages 1-9

  Bastide, Kristell ^a   Ugolin, Nicolas ^a   Levalois, Céline ^a   Bernaudin, Jean François ^b   Chevillard, Sylvie ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Adenocarcinoma; Adenosquamous carcinoma; Gene expression profile; Lung cancer; Rat; Squamous cell carcinoma

Indexed keywords

COMPLEMENTARY DNA; K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RADON; TRANSCRIPTOME;

ADENOSQUAMOUS CARCINOMA; CANCER CLASSIFICATION; DNA SYNTHESIS; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HYBRIDIZATION; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MICROARRAY ANALYSIS; MIXED TUMOR; MOLECULAR GENETICS; MORPHOLOGY; NEUROENDOCRINE SYSTEM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RADIATION EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SQUAMOUS CELL CARCINOMA; UNINDEXED SEQUENCE;

ADENOCARCINOMA; ANIMALS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; GATA6 TRANSCRIPTION FACTOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; LUNG; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MICROARRAY ANALYSIS; MUCIN-1; RADON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, NOTCH2;

EID: 77649343049     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.11.001     Document Type: Review

References (61)

1. Alberg A.J., Brock M.V., and Samet J.M. Epidemiology of lung cancer: looking to the future. J Clin Oncol 23 14 (2005) 3175-3185
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 2 (2005) 74-108
3. Stancu M., and Libbey P.N. In: Weitberg A.B. (Ed). Cancer of the lung: from molecular biology to treatment guidelines (2002), Humana, Totowa, NJ 35-80
4. Travis W.D., Colby T.V., Corrin B., Shimosato Y., and Brambilla E. Histological typing of lung and pleural tumors (1999), Springer-Verlag, Berlin
5. Hsia J.Y., Chen C.Y., Hsu C.P., Shai S.E., and Wang P.Y. Adenosquamous carcinoma of the lung Surgical results compared with squamous cell and adenocarcinoma. Scand Cardiovasc J 33 1 (1999) 29-32
6. Gawrychowski J., Brulinski K., Malinowski E., and Papla B. Prognosis and survival after radical resection of primary adenosquamous lung carcinoma. Eur J Cardiothorac Surg 27 4 (2005) 686-692
7. Nakagawa K., Yasumitu T., Fukuhara K., Shiono H., and Kikui M. Poor prognosis after lung resection for patients with adenosquamous carcinoma of the lung. Ann Thorac Surg 75 6 (2003) 1740-1744
8. Kanazawa H., Ebina M., Ino-Oka N., Shimizukawa M., Takahashi T., Fujimura S., Imai T., and Nukiwa T. Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung. Am J Pathol 156 4 (2000) 1289-1298
9. Monchaux G., Morlier J.P., Altmeyer S., Debroche M., and Morin M. Influence of exposure rate on lung cancer induction in rats exposed to radon progeny. Radiat Res 152 6 Suppl. (1999) S137-S140
10. Hahn F.F., and Boorman G.A. Neoplasia and preneoplasia of the lung. In: Bannasch P., and Gössner W. (Eds). Pathology of neoplasia and preneoplasia in rodents, EULEP Color Atlas vol. 2 (1997), Schattauer, Stuttgart/New York pp. 29-42
11. Chevillard S., Ugolin N., Vielh P., Ory K., Levalois C., Elliott D., Clayman G.L., and El-Naggar A.K. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. Clin Cancer Res 10 19 (2004) 6586-6597
12. Klising-Sireul E., Rigaud O., Ory K., Ugolin N., Lebeau J., Levalois C., Lectard B., and Chevillard S. Transcriptional response of wild-type and ataxia telangiectasia lymphoblasts following exposure to equitoxic doses of ionizing radiation. J Radiat Res (Tokyo) 47 3-4 (2006) 259-272
13. Bishay K., Ory K., Olivier M.F., Lebeau J., Levalois C., and Chevillard S. DNA damage-related RNA expression to assess individual sensitivity to ionizing radiation. Carcinogenesis 22 8 (2001) 1179-1183
14. Chevillard S., Muller A., Levalois C., Laine-Bidron C., Vielh P., and Magdelenat H. Reverse transcription-polymerase chain reaction (RT-PCR) assays of estrogen and progesterone receptors in breast cancer. Breast Cancer Res Treat 41 1 (1996) 81-89
15. Oudard S., Levalois C., Andrieu J.M., Bougaran J., Validire P., Thiounn N., Poupon M.F., Fourme E., and Chevillard S. Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome. Anticancer Res 22 1A (2002) 121-128
16. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 7 (2002) RESEARCH0034
17. Dano L., Guilly M.N., Muleris M., Morlier J.P., Altmeyer S., Vielh P., El-Naggar A.K., Monchaux G., Dutrillaux B., and Chevillard S. CGH analysis of radon-induced rat lung tumors indicates similarities with human lung cancers. Genes Chromosomes Cancer 29 1 (2000) 1-8
18. Ishida T., Kaneko S., Yokoyama H., Inoue T., Sugio K., and Sugimachi K. Adenosquamous carcinoma of the lung clinicopathologic and immunohistochemical features. Am J Clin Pathol 97 5 (1992) 678-685
19. Kikuchi T., Daigo Y., Katagiri T., Tsunoda T., Okada K., Kakiuchi S., Zembutsu H., Furukawa Y., Kawamura M., Kobayashi K., Imai K., and Nakamura Y. Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 22 14 (2003) 2192-2205
20. Yamagata N., Shyr Y., Yanagisawa K., Edgerton M., Dang T.P., Gonzalez A., Nadaf S., Larsen P., Roberts J.R., Nesbitt J.C., Jensen R., Levy S., Moore J.H., Minna J.D., and Carbone D.P. A training-testing approach to the molecular classification of resected non-small cell lung cancer. Clin Cancer Res 9 13 (2003) 4695-4704
21. Kettunen E., Anttila S., Seppanen J.K., Karjalainen A., Edgren H., Lindstrom I., Salovaara R., Nissen A.M., Salo J., Mattson K., Hollmen J., Knuutila S., and Wikman H. Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet Cytogenet 149 2 (2004) 98-106
22. Hofmann H.S., Bartling B., Simm A., Murray R., Aziz N., Hansen G., Silber R.E., and Burdach S. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array. Oncol Rep 16 3 (2006) 587-595
23. Boelens M.C., van den Berg A., Vogelzang I., Wesseling J., Postma D.S., Timens W., and Groen H.J. Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus. J Clin Pathol 60 6 (2007) 608-614
24. Angulo B., Suarez-Gauthier A., Lopez-Rios F., Medina P.P., Conde E., Tang M., Soler G., Lopez-Encuentra A., Cigudosa J.C., and Sanchez-Cespedes M. Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification. J Pathol 214 3 (2008) 347-356
25. Young G.D., Winokur T.S., Cerfolio R.J., Van Tine B.A., Chow L.T., Okoh V., and Garver Jr. R.I. Differential expression and biodistribution of cytokeratin 18 and desmoplakins in non-small cell lung carcinoma subtypes. Lung Cancer 36 2 (2002) 133-141
26. Wikman H., Kettunen E., Seppanen J.K., Karjalainen A., Hollmen J., Anttila S., and Knuutila S. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 21 37 (2002) 5804-5813
27. Su Y.C., Hsu Y.C., and Chai C.Y. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Kaohsiung J Med Sci 22 1 (2006) 14-19
28. Miettinen M., and Sarlomo-Rikala M. Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura. Am J Surg Pathol 27 2 (2003) 150-158
29. Camilo R., Capelozzi V.L., Siqueira S.A., and Del Carlo Bernardi F. Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas. Hum Pathol 37 5 (2006) 542-546
30. Murata K., Ota S., Niki T., Goto A., Li C.P., Ruriko U.M., Ishikawa S., Aburatani H., Kuriyama T., and Fukayama M. p63-key molecule in the early phase of epithelial abnormality in idiopathic pulmonary fibrosis. Exp Mol Pathol 83 3 (2007) 367-376
31. Beckman G., Eklund A., Frohlander N., and Stjernberg N. Haptoglobin groups and lung cancer. Hum Hered 36 4 (1986) 258-260
32. Dobashi Y., Shoji M., Jiang S.X., Kobayashi M., Kawakubo Y., and Kameya T. Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas. Am J Pathol 153 3 (1998) 963-972
33. Yuan A., Yu C.J., Chen W.J., Lin F.Y., Kuo S.H., Luh K.T., and Yang P.C. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Int J Cancer 89 6 (2000) 475-483
34. Amatschek S., Koenig U., Auer H., Steinlein P., Pacher M., Gruenfelder A., Dekan G., Vogl S., Kubista E., Heider K.H., Stratowa C., Schreiber M., and Sommergruber W. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res 64 3 (2004) 844-856
35. Jones J.M., McGonigle N.C., McAnespie M., Cran G.W., and Graham A.N. Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer. Lung Cancer 53 1 (2006) 97-101
36. Moldvay J., Jackel M., Paska C., Soltesz I., Schaff Z., and Kiss A. Distinct claudin expression profile in histologic subtypes of lung cancer. Lung Cancer 57 2 (2007) 159-167
37. Kotoulas C.S., Foroulis C.N., Kostikas K., Konstantinou M., Kalkandi P., Dimadi M., Bouros D., and Lioulias A. Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location. Lung Cancer 44 2 (2004) 183-191
38. Guo M., Akiyama Y., House M.G., Hooker C.M., Heath E., Gabrielson E., Yang S.C., Han Y., Baylin S.B., Herman J.G., and Brock M.V. Hypermethylation of the GATA genes in lung cancer. Clin Cancer Res 10 23 (2004) 7917-7924
39. Rieger E., Bijl J.J., van Oostveen J.W., Soyer H.P., Oudejans C.B., Jiwa N.M., Walboomers J.M., and Meijer C.J. Expression of the homeobox gene HOXC4 in keratinocytes of normal skin and epithelial skin tumors is correlated with differentiation. J Invest Dermatol 103 3 (1994) 341-346
40. Ito T., Udaka N., Yazawa T., Okudela K., Hayashi H., Sudo T., Guillemot F., Kageyama R., and Kitamura H. Basic helix-loop-helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium. Development 127 18 (2000) 3913-3921
41. Carnaghi C., Rimassa L., Garassino I., and Santoro A. Clinical significance of neuroendocrine phenotype in non-small-cell lung cancer. Ann Oncol 12 Suppl. 2 (2001) S119-S123
42. Adjei A.A. The role of mitogen-activated ERK-kinase inhibitors in lung cancer therapy. Clin Lung Cancer 7 3 (2005) 221-223
43. Greenberg A.K., Basu S., Hu J., Yie T.A., Tchou-Wong K.M., Rom W.N., and Lee T.C. Selective p38 activation in human non-small cell lung cancer. Am J Respir Cell Mol Biol 26 5 (2002) 558-564
44. Coe B.P., Lockwood W.W., Girard L., Chari R., Macaulay C., Lam S., Gazdar A.F., Minna J.D., and Lam W.L. Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer. Br J Cancer 94 12 (2006) 1927-1935
45. Vicent S., Lopez-Picazo J.M., Toledo G., Lozano M.D., Torre W., Garcia-Corchon C., Quero C., Soria J.C., Martin-Algarra S., Manzano R.G., and Montuenga L.M. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. Br J Cancer 90 5 (2004) 1047-1052
46. Aviel-Ronen S., Blackhall F.H., Shepherd F.A., and Tsao M.S. K-ras mutations in non-small-cell lung carcinoma: a review. Clin Lung Cancer 8 1 (2006) 30-38
47. Kosaka T., Yatabe Y., Endoh H., Kuwano H., Takahashi T., and Mitsudomi T. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 64 24 (2004) 8919-8923
48. Shigematsu H., Lin L., Takahashi T., Nomura M., Suzuki M., Wistuba I.I., Fong K.M., Lee H., Toyooka S., Shimizu N., Fujisawa T., Feng Z., Roth J.A., Herz J., Minna J.D., and Gazdar A.F. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97 5 (2005) 339-346
49. Shibata T., Hanada S., Kokubu A., Matsuno Y., Asamura H., Ohta T., Sakamoto M., and Hirohashi S. Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma. Cancer Sci 98 7 (2007) 985-991
50. Zacharatos P., Kotsinas A., Tsantoulis P., Evangelou K., Kletsas D., Asimacopoulos P.J., Doussis-Anagnostopoulou I., Pezzella F., Gatter K., Papavassiliou A.G., Kittas C., and Gorgoulis V.G. Relationship of the K-ras/c-mos expression patterns with angiogenesis in non-small cell lung carcinomas. Mol Med 7 9 (2001) 590-597
51. Plummer III H.K., Dhar M., and Schuller H.M. Expression of the alpha7 nicotinic acetylcholine receptor in human lung cells. Respir Res 6 (2005) 29
52. Bumming P., Nilsson O., Ahlman H., Welbencer A., Andersson M.K., Sjolund K., and Nilsson B. Gastrointestinal stromal tumors regularly express synaptic vesicle proteins: evidence of a neuroendocrine phenotype. Endocr Relat Cancer 14 3 (2007) 853-863
53. Willett C.G., Smith D.I., Shridhar V., Wang M.H., Emanuel R.L., Patidar K., Graham S.A., Zhang F., Hatch V., Sugarbaker D.J., and Sunday M.E. Differential screening of a human chromosome 3 library identifies hepatocyte growth factor-like/macrophage-stimulating protein and its receptor in injured lung Possible implications for neuroendocrine cell survival. J Clin Invest 99 12 (1997) 2979-2991
54. Linnoila R.I., Mulshine J.L., Steinberg S.M., Funa K., Matthews M.J., Cotelingam J.D., and Gazdar A.F. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas. Am J Clin Pathol 90 6 (1988) 641-652
55. Ionescu D.N., Treaba D., Gilks C.B., Leung S., Renouf D., Laskin J., Wood-Baker R., and Gown A.M. Nonsmall cell lung carcinoma with neuroendocrine differentiation-an entity of no clinical or prognostic significance. Am J Surg Pathol 31 1 (2007) 26-32
56. Sterlacci W., Fiegl M., Hilbe W., Auberger J., Mikuz G., and Tzankov A. Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected cases. Virchows Arch 455 2 (2009) 125-132
57. Pelosi G., Pasini F., Sonzogni A., Maffini F., Maisonneuve P., Iannucci A., Terzi A., De Manzoni G., Bresaola E., and Viale G. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma. Cancer 97 10 (2003) 2487-2497
58. Berridge M.J., Lipp P., and Bootman M.D. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1 1 (2000) 11-21
59. 2+ for cancer cell proliferation and survival. Nat Rev Cancer 8 5 (2008) 361-375
60. Gudermann T., and Roelle S. Calcium-dependent growth regulation of small cell lung cancer cells by neuropeptides. Endocr Relat Cancer 13 4 (2006) 1069-1084
61. Deberardinis R.J., Sayed N., Ditsworth D., and Thompson C.B. Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 18 1 (2008) 54-61